Company Overview of Burrill Life Sciences Capital Fund III, L.P.
Burrill Life Sciences Capital Fund III, L.P. specializes in seed, early stage, late stage, and mezzanine investments. It prefers to invest in biotechnology, life sciences, pharmaceuticals, diagnostics, devices, human healthcare, wellness and nutraceuticals, agbio, and industrial biotechnology sectors. The fund invests globally. It invests between $1 million and $20 million on an average in its portfolio companies.
One Embarcadero Center
San Francisco, CA 94111
Founded in 2005
Key Executives for Burrill Life Sciences Capital Fund III, L.P.
Similar Private Companies By Industry
|BNY Global Transition Management||United States|
|HDG Mansur Capital Group LLC||United States|
|Canaccord Genuity Inc.||United States|
|Platinum Wealth Partners, Inc.||United States|
|Deutsche Bank Capital Funding Trust IX||United States|
Recent Private Companies Transactions
December 30, 2014
|Neos Therapeutics, Inc.|
To contact Burrill Life Sciences Capital Fund III, L.P., please visit venture.burrillandco.com/funds-23-Burrill_Life_Sciences_Capital_Fund_III_LP__Active.html. Company data is provided by Capital IQ. Please use this form to report any data issues.